Lipopolysaccharide regulates toll-like receptor 4 expression in human aortic smooth muscle cells

Cell Biology International

Volumn 31, Issue 8, 2007, Pages 831-835

  Li, Hongli ^a   He, Ying ^b   Zhang, Jianjun ^a   Sun, Shuhan ^b   Sun, Baogui ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Lipopolysaccharide; Smooth muscle cell; Toll like receptor 4

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

AORTA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

AORTA; CELLS, CULTURED; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH, VASCULAR; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 34248588374     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2007.01.034     Document Type: Article

References (22)

1. Anderson K.V. Toll signaling pathways in the innate immune response. Curr Opin Immunol 12 (2000) 13
2. Antal-Szalmas P. Evaluation of CD14 in host defence. Eur J Clin Invest 30 (2000) 167
3. Edfeldt K., Swedenborg J., Hansson G.K., and Yan Z. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105 (2002) 1158-1161
4. Fan J., Kapus A., Marsden P.A., Li Y.H., Oreopoulos G., Marshall J.C., et al. Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. J Immunol 168 (2002) 5252-5259
5. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., and Goodlet D.R. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410 (2001) 1099-1103
6. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., and Sanjo H. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
7. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162 (1999) 3749
8. Lehr H.A., Sagban T.A., Ihling C., Zahringer U., Hungerer K.D., Blumrich M., et al. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 104 (2001) 914
9. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
10. Means T.K., Wang S., Lien E., Yoshimura A., Golenbock D.T., and Fenton M.J. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163 (1999) 3920
11. Medzhitov R.M., and Janeway Jr. C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91 (1997) 295
12. Michelsen K.S., Wong M.H., Shah P.K., Zhang W., Yano J., Doherty T.M., et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 101 (2004) 10679
13. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., and Gros P. Endotoxin-tolerant mice have mutations in the tlr4 gene. J Exp Med 189 (1999) 615-625
14. Rehli M. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol 23 (2002) 375-378
15. Rice J.B., Stoll L.L., Li W.-G., Denning G.M., Weydert J., Charipar E., et al. Low-level endotoxin induces potent inflammatory activation of human blood vessels inhibition by statins. Arterioscler Thromb Vasc Biol 23 (2003) 1576-1582
16. Sasu S., LaVerda D., Qureshi N., Golenbock D.T., and Beasley D. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 89 (2001) 244-250
17. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., and Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2 (2001) 947-950
18. Stoll L.L., Denning G.M., Li W.G., Rice J.B., Harrelson A.L., Romig S.A., et al. Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J Immunol 173 (2004) 1336-1343
19. Vink A., Schoneveld A.H., van der Meer J.J., van Middelaar B.J., Sluijter J.P.G., and Smeets M.B. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 106 (2002) 1985-1990
20. Wiedermann C.J., Kiechl S., Dunzendorfer S., Schratzberger P., Egger G., Oberhollenzer F., et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 34 (1999) 1975-1981
21. Xu X.H., Shah P.K., Faure E., Equils O., Thomas L., and Fishbein M.C. Toll-like receptor-4 is expressed in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104 (2001) 3103-3108
22. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., and Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163 (1999) 1-5